Newsfeeds - Spark Newswire

1 minute read

Optinose Expects FY23 XHANCE Net Revenues $62.0M-$68.0M, Q1 XHANCE Net Revenues $10.0M

Today, 5:23 AM

The Company expects XHANCE net revenues for the full year of 2023 to be between $62.0 to $68.0 million. XHANCE net revenues attributable to a launch as a treatment for patients with chronic sinusitis are

OPTN

1 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

Today, 5:23 AM

Gainers Brainstorm Cell (NASDAQ:BCLI) stock moved upwards by 20.6% to $2.05 during Friday’s after-market session. The market value…

ANPC

1 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

Today, 5:23 AM

Gainers Cosmos Holdings (NASDAQ:COSM) stock rose 45.1% to $0.48 during Thursday’s pre-market session. The company’s market cap stands…

AIMD

3 minute read

Optinose Announces Pricing Of ~$50M Public Offering Of 26,320,000 Shares Of Common Stock At A Price Of $1.90/Share

By Benzinga Newsdesk

Today, 5:23 AM

Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the pricing of an underwritten public offering of 26,320,000 shares of

OPTN

1 minute read

Optinose Announced On Sept 20 Entered Into Amendment No. 2 To Manufacturing Services Agreement For Sub-Assembly With Advance Mold & Manufacturing; Under Second Amendment, Term Of Manufacturing Services Agreement Has Been Extended To Dec 31, 2025

By Benzinga Newsdesk

Today, 5:23 AM

- Reuters

OPTN

1 minute read

OptiNose Q2 EPS $(0.23) Up From $(0.44) YoY, Sales $20.58M Up From $18.36M YoY

By Benzinga Newsdesk

Today, 5:23 AM

OptiNose (NASDAQ:OPTN) reported quarterly losses of $(0.23) per share. This is a 47.73 percent increase over losses of $(0.44) per share from the same period last year. The company reported $20.58 million in sales this

OPTN

17 minute read

Earnings Scheduled For August 11, 2022

By Benzinga Insights

Today, 5:23 AM

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

AACG

3 minute read

Optinose Announces Additional Results From ReOpen2 And Initial Results From Pooled Analyses Of Both Trials In The ReOpen Program

By Bill Haddad

Today, 5:23 AM

Company previously announced positive top-line results from both ReOpen1 and ReOpen2, the landmark trials evaluating XHANCE as a treatment for chronic sinusitis Multiple secondary endpoints from ReOpen2 indicate

OPTN

2 minute read

Earnings

Looking Into OptiNose’s Return On Capital Employed

By Benzinga Insights

Today, 5:23 AM

Benzinga Pro data, OptiNose (NASDAQ:OPTN) reported Q1 sales of $14.76 million. Earnings fell to a loss of $25.33 million, resulting in a 62.14% decrease from last quarter.

OPTN

5 minute read

71 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:23 AM

Gainers Sidus Space, Inc. (NASDAQ: SIDU) shares jumped 225% to close at $4.68 on Wednesday after the company announced it is part of Collins Aerospace team which was awarded NASA's Exploration Extravehicular Activity services contract with a potential value of $3.5 billion.

ACAD